View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Cirrhosis/Liver Failure News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 08, 2023
2 min read
Save

High out-of-pocket costs may lower rifaximin adherence for hepatic encephalopathy

High out-of-pocket costs may lower rifaximin adherence for hepatic encephalopathy

Researchers reported low rifaximin treatment retention among patients with hepatic encephalopathy, with 30-day out-of-pocket treatment costs in excess of $150 among the factors associated with poor adherence.

SPONSORED CONTENT
September 05, 2023
5 min read
Save

Former Smash Mouth singer’s death underscores need for liver disease awareness

Former Smash Mouth singer’s death underscores need for liver disease awareness

After nearly a decade of health problems, Steve Harwell, former lead singer and frontman for the band Smash Mouth, died Sept. 4 at age 56, which the band’s manager, Robert Hayes, said was caused by acute liver failure.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
August 29, 2023
2 min read
Save

$9.5 million Novo Nordisk grant to fund trial of Ozempic, Wegovy for fibrosis in NAFLD

$9.5 million Novo Nordisk grant to fund trial of Ozempic, Wegovy for fibrosis in NAFLD

Novo Nordisk has awarded a $9.57 million grant supporting a clinical trial at the University of California San Diego NAFLD Research Center to evaluate the use of semaglutide in patients with fibrosis due to nonalcoholic fatty liver disease.

SPONSORED CONTENT
July 26, 2023
1 min read
Save

Higher animal protein intake increases mortality risk in cirrhosis by nearly fourfold

Higher animal protein intake increases mortality risk in cirrhosis by nearly fourfold

Higher intake of total and dairy protein and lower animal protein consumption correlated with a reduced risk for mortality among patients with cirrhosis, according to data published in BMC Gastroenterology.

SPONSORED CONTENT
July 20, 2023
2 min read
Save

Despite narrowing the gap, racial disparities persist in liver transplantation, mortality

Despite narrowing the gap, racial disparities persist in liver transplantation, mortality

Disparities in receipt of liver transplantation and mortality persisted over time among hospitalized Black and Hispanic patients with decompensated cirrhosis compared with their white counterparts, according to data in JAMA Network Open.

SPONSORED CONTENT
July 19, 2023
2 min read
Save

One-fifth of NASH patients develop cirrhosis in 4 years; lower risk for women, nonsmokers

One-fifth of NASH patients develop cirrhosis in 4 years; lower risk for women, nonsmokers

Among patients with nonalcoholic steatohepatitis in the United States, 20% progressed to cirrhosis within 4 years, with female sex and nonsmoking status linked to lower risk for progression, according to data from the TARGET-NASH trial.

SPONSORED CONTENT
July 13, 2023
2 min read
Save

Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis

Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis

Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data presented at EASL Congress.

SPONSORED CONTENT
July 11, 2023
2 min read
Save

Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals

Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals

Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open.

SPONSORED CONTENT
July 10, 2023
8 min watch
Save

VIDEO: ‘Clear correlation’ between IL-31, pruritus in primary biliary cholangitis

VIDEO: ‘Clear correlation’ between IL-31, pruritus in primary biliary cholangitis

In a Healio video exclusive, Andreas Kremer, MD, PhD, MHBA, highlights recent data on primary biliary cholangitis presented at EASL Congress, including risk factors for disease progression and seladelpar for treatment of pruritus.

SPONSORED CONTENT
July 05, 2023
2 min read
Save

Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk

Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk

Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at the EASL Congress.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails